Walter M. Gregory

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · The Lancet · 2010 · 566 citations · Full text

Hematological Malignancy, Zoledronic Acid, Oncology +8

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell et al. · Journal of Clinical Oncology · 2015 · 557 citations · Full text

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

Richard Kelly, Anita Hill, Louise Arnold et al. · Blood · 2011 · 504 citations · Full text

Follicular lymphoma: prognostic factors for response and survival.

C. Gallagher, Walter M. Gregory, A. E. Jones et al. · Journal of Clinical Oncology · 1986 · 430 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +12

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

Andy C. Rawstron, J. A. Child, Ruth M. de Tute et al. · Journal of Clinical Oncology · 2013 · 406 citations